Trials / Completed
CompletedNCT01911078
Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to determine the effects of renal sympathetic denervation on insulin resistance and muscle sympathetic nerve activity in patients with metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Renal Denervation | Renal artery ablation with the EnligHTN™ Renal Denervation System. |
| DEVICE | EnligHTN™ Renal Denervation System. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- Completion
- 2016-06-01
- First posted
- 2013-07-30
- Last updated
- 2019-02-04
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01911078. Inclusion in this directory is not an endorsement.